Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Latest filing published 02 Oct 2026 for Protagonist Therapeutics, Inc, €317k.
Filing timeline
BuySaleAsif Ali
Insider track record
Disclosed buys
0
Disclosed sells
18
Signal history
Asif Ali: trading record in brief
Asif Ali is a declared insider of Protagonist Therapeutics, Inc (finance chief), with filings sourced from SEC (Form 4). The record holds 40 filings, for trades running from 18 April 2022 to 30 September 2026.
No open-market purchase appears, only 18 sales worth €16.3M. The amount is not disclosed for 2 filings. Other entries cover 9 share grants and 13 option exercises. Since January 2026: no purchases and 7 sales on the market.
The record was last updated on 2 October 2026 with an open-market sale (€1.6M) in Protagonist Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Asif Ali
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
9,229 shares@ US$38.98Common StockSEC:0001104659-26-113279:0
28,438 shares@ US$23.42Common StockSEC:0001104659-26-113279:1
15,650 shares@ US$19.19Common StockSEC:0001104659-26-113279:2
5,312 shares@ US$12.17Common StockSEC:0001104659-26-113279:3
12,595 shares@ US$141.77Common StockSEC:0001104659-26-113279:4
46,034 shares@ US$141.78Common StockSEC:0001104659-26-113279:5
1,750 shares@ US$105.470.0018% mcap2.9% of flowCommon StockSEC:0001104659-26-046110:0
19,500 shares@ US$19.196.1% of flowCommon StockSEC:0001104659-26-036317:0
16,000 shares@ US$19.194.8% of flowCommon StockSEC:0001104659-26-007128:0
12,000 shares@ US$12.172.3% of flowCommon StockSEC:0001104659-26-007128:1
28,000 shares@ US$83.1336.7% of flowCommon StockSEC:0001104659-26-007128:2
18,203 shares@ US$83.1423.8% of flowCommon StockSEC:0001104659-26-007128:3
8,588 shares@ US$82.4811.4% of flowCommon StockSEC:0001104659-26-005440:0
25,600 shares0Common StockSEC:0001104659-26-001472:0
1,756 shares@ US$46.001.3% of flowCommon StockSEC:0001104659-25-038036:0
15,203 shares@ US$12.173.2% of flowCommon StockSEC:0001104659-25-024062:0
1,317 shares0Common StockSEC:0001104659-25-004569:0
31,779 shares0Common StockSEC:0001104659-25-001426:0
2,203 shares@ US$44.591.7% of flowCommon StockSEC:0001104659-24-099838:0
1,234 shares@ US$25.110.5% of flowCommon StockSEC:0001104659-24-049567:0
7,850 shares@ US$30.614.1% of flowCommon StockSEC:0001104659-24-030156:0
1,452 shares@ US$24.630.6% of flowCommon StockSEC:0001104659-24-004899:0
21,000 shares0Common StockSEC:0001104659-24-001489:0
12,000 shares0Common StockSEC:0001104659-23-067689:0
1,189 shares@ US$23.210.5% of flowCommon StockSEC:0001104659-23-047208:0
25 of 27 declarations
